SKINPHARMACY ADVANCED ACNE THERAPY OVERNIGHT SALICYLIC ACID

Manufacturer
CVS Health | AMCOL Health & Beauty Solutions, Inc. DBA
Effective date
2017-03-14
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:49:16

Label at a glance#

ProductSKINPHARMACY ADVANCED ACNE THERAPY OVERNIGHT SALICYLIC ACID
Active ingredientsalicylic acid
Label structure8 sections

Dosage and administration

Clean the skin thoroughly before applying this product. Apply a thin layer to affected area once a day before bedtime. If bothersome dryness or peeling occurs, reduce application to every other day. Sensitivity Test for a New User: Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne treatment

Use

INDICATIONS & USAGE SECTION

for the management of acne

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid contact with eyes. If contact occurs, flush thoroughly with water

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. Do not swallow. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product.
  • Apply a thin layer to affected area once a day before bedtime.
  • If bothersome dryness or peeling occurs, reduce application to every other day.
  • Sensitivity Test for a New User: Apply product sparingly to one or two small affected areas during the first 3 days. If no discomfort occurs, follow the directions stated.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Ethoxydiglycol, Ethylhexyl Palmitate, Cetyl Alcohol, Glycerin, Methyl Methacrylate/Glycol Dimethacrylate Crosspolymer, PEG-8, Laureth-4, Dimethicone, Aloe Barbadensis Leaf Juice, Polysorbate 80, DEA-Cetyl Phosphate, Polyacrylamide, Propylene Glycol, Sodium Citrate, Bisabolol, C13-14 Isoparaffin, Xanthan Gum, Disodium EDTA, Diazolidinyl Urea, Methylparaben, Propylparaben

Microsponge® is a registered trademark of AMCOL International Corp.

Save carton for complete labeling since all warnings are not included on the inner package.

Distributed by: CVS Pharmacy, Inc.

One CVS Drive, Woonsocket, RI 02895

© 2014 CVS/pharmacy

CVS.com® 1-800-SHOP CVS

Made in the U.S.A. of U.S. and foreign components

CVS® Quality

Money Back Guarantee

V-13649

PLEASE RECYCLE

V-31490

#987593

FP409

M050790

Principal Display Panel - Carbon Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SKIN+
PHARMACY

ADVANCED
ACNE
THERAPY

OVERNIGHT
SALICYLIC
ACID
LOTION
with Microsponge
®
Technology

Maximum Strength 2% Salicylic Acid

  • works overnight to help eliminate existing blemishes
  • helps prevent new breakouts from forming
  • contains anti-inflammatory Bisabolol & soothing Ale Vera to calm skin
  • fragrance- & oil-free formula

DERMATOLOGIST TESTED

exclusively at
CVS/pharmacy

Actual Size Product
on Side Panel

1 FL OZ (30 mL)

Principal Display Panel - Carbon Label
Principal Display Panel - Carbon Label

Principal Display Panel - Tube Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SKIN+PHARMACY

ADVANCED
ACNE
THERAPY

OVERNIGHT
SALICYLIC ACID LOTION
with Microsponge
® Technology

Maximum Strength
2% Salicylic Acid

  • works overnight to help eliminate existing blemishes
  • helps prevent new breakouts from forming
  • contains anti-inflammatory Bisabolol & soothing Aloe Vera to calm skin
  • fragrance- & oil-free formula

DERMATOLOGIST TESTED

exclusively at
CVS/pharmacy

1 FL OZ (30 mL)

Principal Display Panel - Tube Label
Principal Display Panel - Tube Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
103568salicylic acid 2 % Topical LotionPSN1
103568salicylic acid 20 MG/ML Topical LotionSCD1
103568salicylic acid 2 % Topical LotionSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69842-066-01SKINPHARMACY ADVANCED ACNE THERAPY OVERNIGHT SALICYLIC ACID1 in 1 CARTONLIQUID11
69842-066-01SKINPHARMACY ADVANCED ACNE THERAPY OVERNIGHT SALICYLIC ACID30 mL in 1 TUBELIQUID301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69842-066SKINPHARMACY ADVANCED ACNE THERAPY OVERNIGHT SALICYLIC ACID (SALICYLIC ACID) LIQUID [CVS HEALTH]1Current NDC, Legacy NDC, 2 package rows20170316_534cebb1-1c69-44b0-8407-e5863d7eaa31.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 23 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69842-06669842-066-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SKINPHARMACY ADVANCED ACNE THERAPY OVERNIGHT SALICYLIC ACIDSALICYLIC ACIDCVS Health534cebb1-1c69-44b0-8407-e5863d7eaa312017-03-14WarningsExact identifier
ndc (package): 69842-066-01
ndc (product): 69842-066
ndc11 (package): 69842006601
spl id: aca57bce-04c3-47ee-ad55-0c0957e12453
spl set id: 534cebb1-1c69-44b0-8407-e5863d7eaa31

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.